Jersey: 3R Biotech and Northern Leaf Launch Europe’s First Single-Site Cannabis Plant Health Facility
On the Channel Island of Jersey, the first facility in Europe is being established that consolidates central cannabis plant health services at a single location, according to the companies involved. The project, called „3R Europe,“ is backed by a new partnership between Canadian biotech company 3R Biotech and Northern Leaf, a medicinal cannabis producer based on Jersey.
According to company statements, the facility will be installed at Northern Leaf’s site this month. It will bring together procedures for testing, remediation, preservation, and propagation of cannabis plants in one location for the first time in Europe. The goal is more consistent production for the European medicinal cannabis market: through plant tissue culture, plant material will be standardized, disease risks will be eliminated at the source, and uniform quality will be achieved across the entire production process.
For Northern Leaf, which increased its production capacity by 25 percent last year according to its own accounts, the facility offers the opportunity to store and reproduce plant genetics more consistently. The company produces and dries cannabis flowers as an active pharmaceutical ingredient (API) for export to European markets and does not sell directly to patients or clinics, according to its own statements.
Robert Allen, CEO of 3R Biotech, points to the previously fragmented supply chain: „European medicinal cannabis producers have long sourced plant health services piecemeal—testing from one provider, propagation from another, remediation from a third, and certified, clean genetics from yet somewhere else.“ 3R Europe brings this chain together in one location in Europe for the first time. As cultivation grows, the price of inconsistency becomes more significant, Allen notes; tissue culture is a way to standardize plant material and eliminate disease risks early.
Northern Leaf CEO Steven Tan called the launch a „gateway“ for future plant science on Jersey: „Tissue culture is the foundation that enables everything—from disease-free propagation to advanced breeding techniques to the development of new varieties.“ This gives the company greater control over plant health, genetic integrity, and THC consistency, while expanding the export of cannabis flowers to regulated markets. Long-term, the technology could also benefit other crops on Jersey, such as the Jersey Royal potato.
The setup is being led by Ciara Hayes, Tissue Culture Associate and Jersey-born biomedical graduate. The 24-year-old recently completed training at 3R Biotech in Washington State, where she learned the tissue culture process from the ground up.
For context: Plant tissue culture is a process in which large quantities of identical, healthy plants are grown from very small tissue pieces in a clean, controlled environment. Source: Press release 3R Europe / Northern Leaf.
Wie wichtig ist dir die Konsistenz bei medizinischem Cannabis?
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
